Flavonoids and the Risk of Gastric Cancer: An Exploratory Case-Control Study in the MCC-Spain Study

Autor: Marcela Guevara, Vicente Martín, Beatriz Pérez-Gómez, Guillermo Fernández-Tardón, Juan Pablo Barrio Lera, Rocío Capelo, Dora Romaguera, Rocío Olmedo-Requena, Ana Molina-Barceló, Tania Fernández-Villa, María Rubín-García, Marina Pollán, Raul Zamora-Ros, Victor Moreno, Vasiliki Roussou, Jesús Castilla, Nuria Aragonés, Manolis Kogevinas, Mireia Obón-Santacana, Antonio J. Molina, Facundo Vitelli Storelli, Inés Gómez-Acebo, María Dolores Chirlaque
Přispěvatelé: Instituto de Salud Carlos III, Fundación Marqués de Valdecilla, Ministerio de Economía y Competitividad (España), Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF), International Cancer Genome Consortium, Red Temática de Investigación Cooperativa en Cáncer (España), Regional Government of Andalusia (España), Generalitat Valenciana (España), Basque Government (España), Gobierno de la Región de Murcia (España), Asociación Española Contra el Cáncer, Agencia de Gestio d'Ajuts Universitaris i de Recerca, Fundación Caja de Ahorros de Asturias, University of Oviedo (España), Universidad de Cantabria, UAM. Departamento de Medicina Preventiva y Salud Pública y Microbiología, European Regional Development Fund, Gobierno de Andalucía, Generalitat Valenciana, Gobierno Vasco, Gobierno de Murcia, Fundación Científica AECC, Universidad de Oviedo
Jazyk: angličtina
Rok vydání: 2019
Předmět:
0301 basic medicine
Male
análisis de alimentos
humanos
Physiology
Logistic regression
0302 clinical medicine
Risk Factors
flavonoides
Epidemiology
Odds Ratio
heterocyclic compounds
Flavonoides
mediana edad
neoplasias gástricas
education.field_of_study
anciano
Nutrition and Dietetics
dieta
food and beverages
MCC-Spain
Case-control study
adulto
Middle Aged
cociente de probabilidades relativas
030220 oncology & carcinogenesis
Intake
Dieta
Female
lcsh:Nutrition. Foods and food supply
intake
Adult
medicine.medical_specialty
Farmacologia
Stomach cancer
Medicina
case-control study
Population
estudios de casos y controles
Protective factor
lcsh:TX341-641
macromolecular substances
Article
03 medical and health sciences
Stomach Neoplasms
Statistical significance
medicine
factores de riesgo
Humans
education
Aged
Pharmacology
Flavonoids
business.industry
Càncer d'estómac
gastric cancer
fungi
Cancer
Odds ratio
medicine.disease
Diet
030104 developmental biology
Spain
Case-Control Studies
business
Gastric cancer
Food Analysis
Food Science
Zdroj: Nutrients
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Nutrients. 2019 Apr 27;11(5). pii: E967
Biblos-e Archivo. Repositorio Institucional de la UAM
instname
UCrea Repositorio Abierto de la Universidad de Cantabria
Universidad de Cantabria (UC)
r-FISABIO. Repositorio Institucional de Producción Científica
Nutrients, Vol 11, Iss 5, p 967 (2019)
Volume 11
Issue 5
Dipòsit Digital de la UB
Universidad de Barcelona
Arias Montano. Repositorio Institucional de la Universidad de Huelva
Repisalud
Instituto de Salud Carlos III (ISCIII)
ISSN: 2072-6643
Popis: Several epidemiological studies have investigated the association between the dietary flavonoid intake and gastric cancer (GC) risk
however, the results remain inconclusive. Investigating the relationship between the different classes of flavonoids and the histological types and origin of GC can be of interest to the research community. We used data from a population-based multi-case control study (MCC-Spain) obtained from 12 different regions of Spain. 2700 controls and 329 GC cases were included in this study. Odds ratios (ORs) were calculated using the mixed effects logistic regression considering quartiles of flavonoid intakes and log2. Flavonoid intake was associated with a lower GC risk (ORlog2 = 0.76
95% CI = 0.65&ndash
0.89
ORq4vsq1 = 0.60
95%CI = 0.40&ndash
ptrend = 0.007). Inverse and statistically significant associations were observed with anthocyanidins, chalcones, dihydroflavonols and flavan-3-ols. The isoflavanoid intake was positively associated with higher cancer risk, but without reaching a statistical significance. In general, no differences were observed in the GC risk according to the location and histological type. The flavonoid intake seems to be a protective factor against GC within the MCC-study. This effect may vary depending on the flavonoid class but not by the histological type and location of the tumor. Broader studies with larger sample size and greater geographical variability are necessary.
Databáze: OpenAIRE